Table 3.

Circulating miRNAs in stroke follow-up patients versus healthy controls.

	Discovery		Validation		Combined
miRNA	Log2FC 1	FDR 2	Log2FC 1	FDR 2	Log2FC 1	FDR 2
hsa-miR-451a	2.2	1.09 × 10−19	2.6	4.46 × 10−22	2.3	2.03 × 10−45
hsa-miR-224-5p	−2.5	2.68 × 10−17	−2.1	1.17 × 10−08	−2.3	2.04 × 10−27
hsa-miR-6721-5p	−2.8	2.07 × 10−08	−2.2	5.38 × 10−05	−2.4	1.98 × 10−15
hsa-miR-142-3p	−2.3	2.85 × 10−34	−2.2	2.16 × 10−29	−2.3	6.91 × 10−77
hsa-miR-411-5p	−2.9	2.13 × 10−11	−2.5	7.66 × 10−07	−2.8	4.52 × 10−25
hsa-miR-379-5p	−2.8	4.15 × 10−22	−2.6	1.43 × 10−13	−2.7	1.17 × 10−44
hsa-miR-149-5p	−3.4	5.20 × 10−04	−3.0	2.00 × 10−03	−3.3	1.06 × 10−11

¹ Log₂ fold change; ² false discovery rate.